Analysts have been eager to weigh in on the Healthcare sector with new ratings on ICU Medical (ICUI – Research Report), Twist Bioscience (TWST – Research Report) and Alignment Healthcare (ALHC – Research Report).
ICU Medical (ICUI)
In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on ICU Medical, with a price target of $208.00. The company’s shares closed last Friday at $179.63.
According to TipRanks.com, Bedford is a 5-star analyst with an average return of
ICU Medical has an analyst consensus of Moderate Buy, with a price target consensus of $219.00, implying a 26.1% upside from current levels. In a report issued on August 3, KeyBanc also maintained a Buy rating on the stock with a $230.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Twist Bioscience (TWST)
In a report released today, Puneet Souda from SVB Securities maintained a Hold rating on Twist Bioscience, with a price target of $50.00. The company’s shares closed last Friday at $52.77.
According to TipRanks.com, Souda is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Twist Bioscience with a $53.67 average price target.
Alignment Healthcare (ALHC)
Raymond James analyst John Ransom maintained a Buy rating on Alignment Healthcare today and set a price target of $22.00. The company’s shares closed last Friday at $17.91.
According to TipRanks.com, Ransom is a 5-star analyst with an average return of
Alignment Healthcare has an analyst consensus of Strong Buy, with a price target consensus of $18.00, representing a 0.1% upside. In a report issued on August 5, Piper Sandler also maintained a Buy rating on the stock with a $20.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ICUI:
- Credit Suisse Reaffirms Their Hold Rating on TELUS International (CDA) (TIXT)
- Credit Suisse Keeps Their Hold Rating on TripAdvisor (TRIP)
- Raymond James Remains a Buy on United States Cellular (USM)
- Wells Fargo Sticks to Their Hold Rating for UGI (UGI)
- Wells Fargo Keeps Their Buy Rating on Brookfield Renewable Partners (BEP)